scholarly journals Extracorporeal shock wave therapy as a potential therapeutic tool for breast cancer related lymphedema: a narrative review of in vitro, animal and clinical studies

2021 ◽  
Vol 15 (1) ◽  
pp. 1-12
Author(s):  
Julia Konrad ◽  
Magdalena Grygiel
Keyword(s):  
Breast Cancer ◽  
Shock Wave ◽  
Clinical Trials ◽  
Animal Experiments ◽  
Extracorporeal Shock Wave Therapy ◽  
Shock Wave Therapy ◽  
Therapeutic Tool ◽  
Extracorporeal Shock Wave ◽  
Breast Cancer Related Lymphedema

Background: The treatment of breast cancer related lymphedema (BCRL) focuses on the alleviation symptoms. One of the innovative, non-invasive therapies used for this condition is extracorporeal shock wave therapy (ESWT). Aim of the study: To review the available literature and evaluate the effectiveness of ESWT in the treatment of secondary lymphedema (in vitro works, animal experiments) and lymphedema associated with the treatment of breast cancer. Material and methods: The scientific literature review was conducted from October to December 2020. The review was carried out by searching scientifically recognized medical databases, including PubMed, MEDLINE and PEDro. Date restrictions were not applied. As there are only a few clinical studies assessing the effectiveness of ESWT on the reduction of lymphedema, case reports, animal experiments and in vitro works were included in the review. Articles written in a language other than English were excluded. Results: In total, the analysis included twelve studies, including seven clinical trials, one case report, three animal experiments and one in vitro test. Conclusions: Based on the results of the analyzed articles, ESWT can be an effective therapeutic tool for lymphedema occurring after breast cancer treatment. Unfortunately, the level of evidence is relatively weak since the number of publications on this subject is still quite low. The accumulated results indicate the need for further clinical trials.

scholarly journals THE EFFECTIVENESS OF EXTRACORPOREAL SHOCK WAVE THERAPY ON BREAST CANCER-RELATED LYMPHEDEMA: A LITERATURE REVIEW

Lymphology ◽  
2021 ◽  
Vol 53 (3) ◽  
Author(s):  
S Miccinilli ◽  
M Bravi ◽  
M Maselli ◽  
F Santacaterina ◽  
M Morrone ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Shock Wave ◽  
Extracorporeal Shock Wave Therapy ◽  
Breast Cancer Surgery ◽  
Treatment Modalities ◽  
Cochrane Library ◽  
Shock Wave Therapy ◽  
High Quality Research ◽  
Extracorporeal Shock Wave ◽  
Breast Cancer Related Lymphedema

Lymphedema is one of the most dreaded complications related to breast cancer surgery, commonly resulting in upper limb functional, esthetic, and psychological impairment. The necessity to improve the efficacy of conventional treatments and the promising effect of extracorporeal shock wave therapy (ESWT) on lymphangiogenesis in vitro and animal models, has prompted studies involving women affected by breast-cancer related lymphedema. Since intervention modalities and treatment protocols used are different, a review is necessary to verify the effectiveness of ESWT, evaluating the quality of existing studies and the eventual need for further research. Data were obtained from PubMed, Scopus, Google Scholar, Cochrane Library and PEDro, including articles published until January 2019. Five studies met the inclusion criteria. Evident heterogeneity emerged among selected studies permitting only a purely descriptive analysis of their data and strongly limiting their comparison. When compared to other treatment modalities, ESWT showed a significant effect on measured outcomes. It is clear that further high quality research is necessary to assert with confidence the effects and possible superiority of ESWT over other conservative therapies in the management of breast-cancer related lymphedema.

scholarly journals Extracorporeal Shock Wave Therapy Combined with Complex Decongestive Therapy in Patients with Breast Cancer-Related Lymphedema: A Systemic Review and Meta-Analysis

2021 ◽  
Vol 10 (24) ◽  
pp. 5970
Author(s):  
Yu Lin Tsai ◽  
Ting Jie I ◽  
Ya Chi Chuang ◽  
Yuan Yang Cheng ◽  
Yu Chun Lee
Keyword(s):  
Breast Cancer ◽  
Shock Wave ◽  
Meta Analysis ◽  
Extracorporeal Shock Wave Therapy ◽  
Systemic Review ◽  
Skin Thickness ◽  
Shock Wave Therapy ◽  
Complex Decongestive Therapy ◽  
Extracorporeal Shock Wave ◽  
Breast Cancer Related Lymphedema

Breast cancer-related lymphedema (BCRL) is one of the most significant complications seen after surgery. Several studies demonstrated that extracorporeal shock wave therapy (ESWT), in addition to conventional complex decongestive therapy (CDT), had a positive effect on BCRL in various aspects. The systematic review and meta-analysis aim to explore the effectiveness of ESWT with or without CDT on BRCL patients. We searched PubMed, Embase, PEDro, Cochrane Library Databases, and Google Scholar for eligible articles and used PRISMA2020 for paper selection. Included studies were assessed by the PEDro score, Modified Jadad scale, STROBE assessment, and GRADE framework for the risk of bias evaluation. The primary outcomes were the volume of lymphedema and arm circumference. Secondary outcome measures were skin thickness, shoulder joint range of motion (ROM), and an impact on quality-of-life questionnaire. Studies were meta-analyzed with the mean difference (MD). Eight studies were included in the systemic review and four in the meta-analysis. In summary, we found that adjunctive ESWT may significantly improve the volume of lymphedema (MD = −76.44; 95% CI: −93.21, −59.68; p < 0.00001), skin thickness (MD = −1.65; 95% CI: −3.27, −0.02; p = 0.05), and shoulder ROM (MD = 7.03; 95% CI: 4.42, 9.64; p < 0.00001). The evidence level was very low upon GRADE appraisal. ESWT combined with CDT could significantly improve the volume of lymphedema, skin thickness, and shoulder ROM in patients with BCRL. There is not enough evidence to support the use of ESWT as a replacement for CDT. This study was registered with PROSPERO: CRD42021277110.

Extracorporeal Shock Wave Therapy for Breast Cancer–Related Lymphedema: A Pilot Study

2016 ◽  
Vol 97 (9) ◽  
pp. 1520-1525 ◽  
Author(s):  
Mehtap Aykac Cebicci ◽  
Serap Tomruk Sutbeyaz ◽  
Sema Sezgin Goksu ◽  
Sehriban Hocaoglu ◽  
Arzu Oguz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Shock Wave ◽  
Pilot Study ◽  
Extracorporeal Shock Wave Therapy ◽  
Shock Wave Therapy ◽  
Extracorporeal Shock Wave ◽  
Breast Cancer Related Lymphedema

scholarly journals Effect of extracorporeal shock wave therapy on equine umbilical cord blood mesenchymal stromal cells in vitro

2020 ◽  
Author(s):  
Ramés Salcedo-Jiménez ◽  
Judith Koenig ◽  
Olivia Lee ◽  
Thomas W.G. Gibson ◽  
Pavneesh Madan ◽  
...  
Keyword(s):  
Shock Wave ◽  
Mesenchymal Stromal Cells ◽  
Umbilical Cord Blood ◽  
Stromal Cells ◽  
Extracorporeal Shock Wave Therapy ◽  
Shock Wave Therapy ◽  
Extracorporeal Shock Wave ◽  
Immunomodulatory Properties

AbstractExtracorporeal shock wave therapy (ESWT) has been shown to induce different biological effects on a variety of cells, including regulation and stimulation of their function and metabolism. ESWT can promote different biological responses such as proliferation, migration, and regenerations of cells. Recent studies have shown that mesenchymal stromal cells (MSCs) secrete factors that enhance the regeneration of tissues, stimulate proliferation and differentiation of cells and decrease inflammatory and immune-reactions. Clinically, the combination of these two therapies has been used as a treatment for tendon and ligament lesions in horses; however, there is no scientific evidence supporting this combination of therapies in vivo. Therefore, the objectives of the study were to evaluate the effects of ESWT on equine umbilical cord blood mesenchymal stromal cells (CB-MSCs) proliferative, metabolic, migrative, differentiation, and immunomodulatory properties in vitro. Three equine CB-MSC cultures from independent donors were treated using an electrohydraulic shock wave generator attached to a water bath. All experiments were performed as triplicates. Proliferation, viability, migration and immunomodulatory properties of the cells were evaluated. Equine CB-MSCs were induced to evaluate their trilineage differentiation potential. ESWT treated cells had increased metabolic activity, showed positive adipogenic, osteogenic, and chondrogenic differentiation, and showed higher potential for differentiation towards the adipogenic and osteogenic cell fates. ESWT treated cells showed similar immunomodulatory properties to none-ESWT treated cells. Equine CB-MSCs are responsive to ESWT treatment and showed increased metabolic, adipogenic and osteogenic activity, but unaltered immunosuppressive properties. In vivo studies are warranted to determine if synergistic effects occur in the treatment of musculoskeletal injuries if ESWT and equine CB-MSC therapies are combined.

scholarly journals Radial Extracorporeal Shock Wave Therapy against Cutibacterium acnes Implant-Associated Infections: An in Vitro Trial

2020 ◽  
Vol 8 (5) ◽  
pp. 743
Author(s):  
Konstantinos Tsikopoulos ◽  
Lorenzo Drago ◽  
Georgios Koutras ◽  
Panagiotis Givissis ◽  
Eleni Vagdatli ◽  
...  
Keyword(s):  
Shock Wave ◽  
Untreated Control ◽  
Low Frequency ◽  
Extracorporeal Shock Wave Therapy ◽  
Multi Drug Resistance ◽  
Shock Wave Therapy ◽  
Control Groups ◽  
Extracorporeal Shock Wave ◽  
Cutibacterium Acnes

Background: Antibiotic management of low-virulent implant-associated infections induced by Cutibacterium acnes may be compromised by multi-drug resistance development, side effects, and increased cost. Therefore, we sought to assess the effects of shock wave therapy against the above pathogen using an in vitro model of infection. Methods: We used a total of 120 roughened titanium alloy disks, simulating orthopedic biomaterials, to assess the results of radial extracorporeal shock wave therapy (rESWT) against C. acnes (ATCC 11827) biofilms relative to untreated control. In particular, we considered 1.6 to 2.5 Bar with a frequency ranging from 8–11 Hz and 95 to 143 impulses per disk to investigate the antibacterial effect of rESWT against C. acnes planktonic (free-floating) and biofilm forms. Results: Planktonic bacteria load diminished by 54% compared to untreated control after a 1.8-bar setting with a frequency of 8 Hz and 95 impulses was applied (median absorbance (MA) for intervention vs. control groups was 0.9245 (IQR= 0.888 to 0.104) vs. 0.7705 (IQR = 0.712 to 0.864), respectively, p = 0.001). Likewise, a statistically significant reduction in the amount of biofilm relative to untreated control was documented when the above setting was considered (MA for treatment vs biofilm control groups was 0.244 (IQR= 0.215–0.282) and 0.298 (IQR = 0.247–0.307), respectively, p = 0.033). Conclusion: A 50% biofilm eradication was documented following application of low-pressure and low-frequency radial shock waves, so rESWT could be investigated as an adjuvant treatment to antibiotics, but it cannot be recommended as a standalone treatment against device-associated infections induced by C. ances.

scholarly journals Extracorporeal Shock Wave Therapy Promotes Osteogenic Differentiation in a Rabbit Osteoporosis Model

2021 ◽  
Vol 12 ◽  
Author(s):  
Baofeng Li ◽  
Renkai Wang ◽  
Xianyin Huang ◽  
Yongliang Ou ◽  
Zhenyu Jia ◽  
...  
Keyword(s):  
Shock Wave ◽  
Bone Formation ◽  
Osteogenic Differentiation ◽  
Extracorporeal Shock Wave Therapy ◽  
Shock Wave Therapy ◽  
Detailed Mechanism ◽  
Extracorporeal Shock Wave ◽  
Osteoblast Maturation

Extracorporeal shock wave therapy (ESWT) has been identified to accelerate bone formation. However, detailed mechanism has not been fully explained. In this study, we found that ESWT promoted osteoblast formation in vitro. Local ESW treatment of femur increased bone formation in vivo. Furthermore, changing the density or frequency of energy, there was no statistical difference in osteogenic differentiation. Therapeutically, local ESW therapy relieved bone loss and increased the number of bone trabecular in a rabbit osteoporosis model and promoted endogenous levels of SMAD2 protein expression. Thus, ESWT may be a potential therapy by promoting osteoblast maturation through TGF-β/SMAD2 pathway.

Extracorporeal Shock Wave Therapy for Peyronie's Disease: Exploratory Meta-Analysis of Clinical Trials

2004 ◽  
Vol 171 (2) ◽  
pp. 740-745 ◽  
Author(s):  
EKKEHARD W. HAUCK ◽  
ULRICH O. MUELLER ◽  
THOMAS BSCHLEIPFER ◽  
HANS U. SCHMELZ ◽  
THORSTEN DIEMER ◽  
...  
Keyword(s):  
Shock Wave ◽  
Clinical Trials ◽  
Meta Analysis ◽  
Extracorporeal Shock Wave Therapy ◽  
Peyronie’S Disease ◽  
Shock Wave Therapy ◽  
Extracorporeal Shock Wave ◽  
Peyronie's Disease
Sign in / Sign up

Export Citation Format

Share Document